A review study conducted by experts from the Vall d'Hebron Research Institute has demonstrated the effectiveness of methylphenidate, a drug so far only used on children with attention deficit hyperactivity disorder (ADHD), for treating this disorder in adults

STAFF | FEBRUARY 25TH, 2011

A study by the Gene Expression and Cancer research group of the Vall d'Hebron Oncology Institute (VHIO) in Barcelona has identified genetic markers that indicate which cells are responsible for a tumor’s onset and recurrence. The possession of this information is useful in determining what treatments do or do not eliminate these cells

STAFF | DECEMBER 14TH, 2010

Researchers at the Vall d'Hebron Research Institute (VHIR) have identified a gene associated with multiple sclerosis. Specifically, it is related to a variant of the disease called primary progressive that mainly afflicts the male population.

STAFF | NOVEMBER 4TH, 2010

A team of researchers at the Vall d'Hebron Research Institute (VHIR) in Barcelona, Spain, have studied the immune response in patients who required admission to the ICU for severe pneumonia during the acute phase of swine flu. The study's findings indicate that in the most serious cases, the failure of the immune response is unable to prevent the virus from replicating and this causes a vicious cycle that worsens the patient’s clinical status to a critical situation.

STAFF | SEPTEMBER 28TH, 2010